H. Haverkamp

Forschung für neue Technologien und ihre Wechselwirkung mit der Industrie - Vom Mittelständler zum Global Player (2008)

Nussbaumer, H., Biro, D., Haverkamp, H., Bothe, K.

Minimizing the electrical losses on the front side: Development of a selective emitter process from a single diffusion (2008)

Haverkamp, H., Shirazi, A., Raabe, B., Book, F., Hahn, G.

In this paper we present latest results in the development of a process for the fabrication of a selective emitter structure on mono- and multicrystalline silicon solar cells. The process is based on...

Verfahren zum Fertigen einer Silizium-Solarzelle mit einem selektiven Emitter sowie entsprechende Solarzelle (2007)

Hahn, G., Haverkamp, H., Raabe, B.

WO 2009013307 A2 UPAB: 20090220 NOVELTY - The method involves producing a two-dimensionally extending emitter (5) at an emitter surface of a solar cell substrate (21). A porous silicon layer (27) is...

Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group (2007)

Klimm, B, Eich, HT, Haverkamp, H, Lohri, A, Koch, P, Boissevain, F, ...

Background: The optimal treatment of elderly patients with Hodgkin's lymphoma (HL) is still a matter of debate. Since many of these patients receive combined modality treatment, we evaluated the...

Verfahren zum Fertigen einer Silizium-Solarzelle mit einem rueckgeaetzten Emitter sowie entsprechende Solarzelle (2007)

Hahn, G., Haverkamp, H., Raabe, B., Dastgheib-Shirazi, A., Bock, F.

(A1) Es wird ein Verfahren zum Fertigen einer Silizium-Solarzelle mit einem rueckgeaetzten, vorzugsweise mit einem selektiven Emitter und eine entsprechende Solarzelle vorgestellt. Gemaess einem...

Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group (2006)

Klimm, B., Eich, H. T., Haverkamp, H., Lohri, A., Koch, P., Boissevain, F., ...

Background: The optimal treatment of elderly patients with Hodgkin's lymphoma (HL) is still a matter of debate. Since many of these patients receive combined modality treatment, we evaluated the...

Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group (2006)

Klimm, B., Eich, H. T., Haverkamp, H., Lohri, A., Koch, P., Boissevain, F., ...

Background: The optimal treatment of elderly patients with Hodgkin's lymphoma (HL) is still a matter of debate. Since many of these patients receive combined modality treatment, we evaluated the...

A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly) (2005)

Ballova, V., Haverkamp, H., Pfistner, B., Müller-Hermelink, H. K., Dühmke, E., ...

In contrast to younger patients, the prognosis of elderly patients with advanced Hodgkin's disease (HD) has not improved substantially over the last 20 years. We thus carried out a prospectively...

Cost-benefit analysis of a plant sterol containing low-fat margarine for cholesterol reduction

A. Gerber, T. Evers, H. Haverkamp, K. Lauterbach

Cholesterol reduction, Coronary heart disease, Cost-benefit analysis, Low-fat margarine, Low-fat plant sterol,